Lot-to-lot Consistency of Sci-B-Vac™ in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

2,838

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2019

Conditions
Hepatitis B Vaccines
Interventions
BIOLOGICAL

Hepatitis B Vaccination

Hepatitis B Vaccination

Trial Locations (26)

30281

Clinical Research Altanta, Atlanta

32720

Avail Clinical Research, DeLand

33135

Suncoast Research Group, Miami

35216

Accel Research Sites, Birmingham

43213

Aventiv Research Inc, Columbus

44122

Rapid Medical Research, Cleveland

59808

Montana Medical Research, LLC, Missoula

73112

Lynn Health Science Institute, Oklahoma City

83642

Advanced Clinical Research (ACR), Boise

84088

Advanced Clinical Research (ACR), Salt Lake City

85283

Clinical Research Consortium Arizona, LLC, Tempe

89104

Clinical Research Center of Nevada, Las Vegas

90036

Ruane Clinical Research Group Inc, Los Angeles

91606

CareOne Research, North Hollywood

92801

Anaheim Clinical Trials, Anaheim

Unknown

Universitair Ziekenhuis Gent, Ghent

Medicore Research Inc, Greater Sudbury

Manna Toronto, Toronto

Manna Montreal, Montreal

Manna Research Quebec, Québec

University of Tampere, Tampere

Medizinishe Hochschule Hannover, Hanover

Oxford University, Oxford

Bristol Royal Hospital for Children, Bristol

St. George's University Hospital NHS Foundation Trust, London

Southampton General Hospital, Southampton

All Listed Sponsors
lead

VBI Vaccines Inc.

INDUSTRY

NCT03408730 - Lot-to-lot Consistency of Sci-B-Vac™ in Adults | Biotech Hunter | Biotech Hunter